Displaying items by tag: school of medicine
Disruption of Blimp1 in regulatory T cells remodels the tumor microenvironment and augments the response to immunotherapy.
Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.
This revitalization kick-off event follows ribbon-cuttings held in two other Live HealthSmart Alabama demonstration communities, Titusville and Kingston, earlier this year.
UAB’s Know Overdose Initiative seeks to educate, identify and prescribe Naloxone for individuals who have been identified as high risk for overdose.
UAB neonatologist aims to support literacy from birth through his new Baby Bookworms book and reading program study.
At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.
The PPMI study is looking for biomarkers for Parkinson’s disease, which would help identify those at risk and track the progression of the disease.
UAB O’Neal Comprehensive Cancer Center, Morehouse School of Medicine and Tuskegee University collectively receive $18 million U54 grant from the National Cancer Institute.
After years of researching the SON gene, Erin Eun-Young Ahn, Ph.D., may have found the cause behind an extremely rare disease.
Recent studies have shown that formal exercise training can help boost memory, and memory deficit is relatively common in people with epilepsy.
Kirklin received this award for his dedication to advancing the science and treatment of children through the journey of heart transplantation.